Simultaneously, PI3K/Akt/mTOR synergizes with NF-κB by promoting IκB kinase phosphorylation and suppressing apoptosis, thereby fine-tuning immune responses, tumor metabolism, and ultimately influencing therapeutic efficacy (49, 50). The gene discussed is AKT1; the disease is neoplasm.